| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 08/05/2009 | EP1399116B1 Use of dicationic compounds for dyeing human keratinous fibres and compositions containing same |
| 08/05/2009 | EP1383731B1 Biaryl compounds as serine protease inhibitors |
| 08/05/2009 | EP1249233B9 Npyy5 antagonists |
| 08/05/2009 | CN101501005A Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use |
| 08/05/2009 | CN101501004A Compounds and compositions as HEDGEHOG signaling pathway modulators |
| 08/05/2009 | CN101498005A Method for preparing metal complex |
| 08/05/2009 | CN100522965C 8-arylamine-3H-imidazole [4,5-g] quinazoline derivatives and its solid phase synthesis method |
| 08/05/2009 | CN100522952C Insecticidal phthalamide derivatives |
| 08/05/2009 | CN100522937C Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 08/05/2009 | CN100522931C 2-substituted rubrene compound and its synthesis method and application |
| 08/05/2009 | CN100522171C 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 08/05/2009 | CN100522150C Angiogenesis inhibitor |
| 08/04/2009 | US7569703 Fluorinating agent and method for producing fluorine-containing compound using the same |
| 08/04/2009 | US7569702 Iodinating a 4-nitroimidazole compound substituted with a chlorine atom or bromine atom, and then reducing the obtained 5-iodo-4-nitroimidazole compound; high yield and high purity; safe method causing few dangers such as explosion |
| 08/04/2009 | US7569701 Crystal form of 5-hydroxy-1-methylimidazolidin-2,4-dione |
| 08/04/2009 | US7569596 e.g. N1-[(E)-1-(4-fluorophenyl)methylidene]-4-(1,3-thiazol-2-yl)-1H-1,2-imidazolediamine; anticarcinogenic agent; sid effect reduction |
| 08/04/2009 | US7569595 Selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; treating pain, visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
| 08/04/2009 | US7569584 4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the same |
| 08/04/2009 | US7569079 Hair affinity; light and shampooing fastness; such as 1-(6-{3-[4-(1H-imidazol-1-yl)butyl]-1H-imidazol-3-ium-1-yl}hexyl)-4-{[methyl(phenyl)hydrazono]methyl}quinolinium dibromide; multicompartment cosmetic kits |
| 07/30/2009 | WO2009067600A3 Biaryl pde4 inhibitors for treating inflammation |
| 07/30/2009 | US20090192206 Mercaptoimidazoles as ccr2 receptor antagonists |
| 07/30/2009 | US20090192136 Benzoyl-piperazine derivatives |
| 07/30/2009 | US20090192096 2'-Substituted 1,1'-Biphenyl-2-Carboxamides, Processes For Their Preparation, Their Use As Medicaments, And Pharmaceutical Preparations Comprising Them |
| 07/30/2009 | US20090191262 Use of compounds of formula a-r-xo pharmaceutically acceptable salts thereof for producing a pharmaceutically preparations |
| 07/29/2009 | EP2083005A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 07/29/2009 | EP2082740A2 Use of imidazole derivatives as MDR modulators |
| 07/29/2009 | EP2082041A2 Novel genes related to glutaminyl cyclase |
| 07/29/2009 | EP2081911A2 Cyclopropanecarboxylates and use thereof as pesticides |
| 07/29/2009 | EP2081905A2 Sulfonyl compounds which modulate the cb2 receptor |
| 07/29/2009 | EP2081888A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 07/29/2009 | EP1807407B1 Aromatic amides as inhibitors of c-fms kinase |
| 07/29/2009 | EP1513527B1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers |
| 07/29/2009 | EP1409468B9 Guanidinobenzamides as mc4-r agonists |
| 07/29/2009 | EP1268443B1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/29/2009 | CN101495458A Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors |
| 07/29/2009 | CN101492424A Actinochemical synthesis of 1H-imidazole-5-carboxylic acid ester compounds |
| 07/29/2009 | CN101492423A Method for preparing achromatic imidazole ionic liquids |
| 07/29/2009 | CN101492422A Alkyl imidazole succinimide ionic liquid and method for preparing the same |
| 07/29/2009 | CN101492416A Compounds effecting glucokinase |
| 07/29/2009 | CN100519538C Method for preparing 1,3-dialkyl-2-imidazolidinone and 1,5- dialkyl-(1,3,5)triazahepane-2,4-diketone |
| 07/28/2009 | US7566803 Vitamin D receptor modulators |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566715 Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system |
| 07/23/2009 | WO2009091759A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | WO2009091735A1 Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/23/2009 | WO2009050352A3 Imidazolone derivatives, preparation method thereof and biological use of same |
| 07/23/2009 | WO2008103351A3 Heterocyclic aspartyl protease inhibitors |
| 07/23/2009 | US20090186930 Novel imidazole derivatives, preparation and user thereof as medicine |
| 07/23/2009 | US20090186905 Anaplastic lymphoma kinase modulators and methods of use |
| 07/23/2009 | US20090186834 Diphenylheterocycle cholesterol absorption inhibitors |
| 07/23/2009 | CA2712262A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | CA2712256A1 Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/22/2009 | EP2080756A2 Method for making losartan |
| 07/22/2009 | EP2079708A2 Acyl aminoimidazoles and acyl aminothiazoles |
| 07/22/2009 | EP2079707A2 Method for reacting 1,3-heteroaromatic 2-carboxylates with water |
| 07/22/2009 | EP2079706A1 Method for preparing medetomidine and its salts |
| 07/22/2009 | EP2079705A1 Method for producing quaternary carbonates |
| 07/22/2009 | EP2079525A1 Calcium receptor modulating agents |
| 07/22/2009 | EP1773785A4 High stability diionic liquid salts |
| 07/22/2009 | EP1727540A4 Melanin-concentrating hormone receptor antagonists and methods of use |
| 07/22/2009 | EP1644337B1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | CN101490013A Method for producing imidazolidine-2,4-dione compound and method for obtaining solid 4,5-dihydroxy-2-imidazolidinone compound |
| 07/22/2009 | CN101486681A Method for producing azathiopurine intermediate and product produced thereby |
| 07/22/2009 | CN101486680A Method for industrial production of miconazole nitrate |
| 07/22/2009 | CN100516050C Diphenyl imidazole compound containing fluorine atom |
| 07/22/2009 | CN100516041C Novel heteroaryl derivative |
| 07/21/2009 | US7563906 Indazole derivatives |
| 07/21/2009 | US7563902 Chemiluminescent compounds and their use |
| 07/21/2009 | US7563814 Olmesartan medoxomil with reduced levels of impurities |
| 07/21/2009 | CA2287165C Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same |
| 07/16/2009 | WO2009089448A1 Therapeutic disulfide compounds for treating pain and diabetes |
| 07/16/2009 | WO2009089132A1 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/16/2009 | WO2009087184A1 Process for working up ionic liquids |
| 07/16/2009 | US20090182144 Binding inhibitor of sphingosine-1-phosphate |
| 07/16/2009 | US20090182026 Alpha 2 adrenergic agonists |
| 07/16/2009 | US20090181949 1h-imidazole derivative having cb1, agonistic, cb1 partial agonistic or cb1 antagnistic activity |
| 07/16/2009 | CA2711464A1 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/15/2009 | EP2078714A2 Imidazolinum salts with low melting points, method for their manufacture and their use as lubricant |
| 07/15/2009 | EP1709005B1 High purity butoconazole nitrate with specified particle size and a process for preparation thereof |
| 07/15/2009 | EP1529037B1 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 07/15/2009 | EP1379514B1 5-membered heterocycles, preparation and application thereof as medicaments |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN101481354A 5-(4-phenol methylene)-2-thio-2,4-imidazolinedione ester and use thereof |
| 07/15/2009 | CN100513386C Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 07/14/2009 | US7560571 anticarcinogenic agent, 3-{4-[3-(2-Fluoro-5-trifluoromethylphenyl)ureido]phenyl}-1H-pyrrole-2-carboxamide, for treating cancer; modulating Protein kinases, relieve the side effect of chemotherapy |
| 07/14/2009 | US7560570 Inhibitors of fatty acid amide hydrolase |
| 07/14/2009 | US7560483 Synthesizing 1- (acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amenable |
| 07/14/2009 | US7560477 Compounds active in sphingosine 1-phosphate signaling |
| 07/14/2009 | US7560475 3-(2-{5-methyl-2-[4-(trifluoromethyl)piperidin-1-yl]-1,3-thiazol-4-yl}ethoxy)phenyl]acetic acid,peroxime proliferator-activated receptor antagonists; side effect reduction; very low toxicity, especially hepatotoxicity; metabolic disorders; antidiabetic agents; anticholesterol agents; antilipemic agents |
| 07/14/2009 | US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR) |
| 07/14/2009 | CA2390933C Oral solid preparation comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide |
| 07/14/2009 | CA2309279C Polymerization process with living characteristics and polymers made therefrom |
| 07/13/2009 | CA2711728A1 Novel imidazolinylmethyl aryl sulfonamides |
| 07/09/2009 | WO2009084614A1 Imidazole carbonyl compound |
| 07/09/2009 | WO2008154642A3 Antibacterial agents |
| 07/09/2009 | US20090176963 Organic-acid-based catalyst for production of polylactic acid |
| 07/09/2009 | US20090176853 Adamantane derivatives |
| 07/09/2009 | US20090176850 Novel 2-Amino-Imidazole-4-One Compounds And Their Use In The Manufacture Of A Medicament To Be Used In The Treatment Of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration And Dementia |
| 07/09/2009 | US20090176843 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |